Pharmacologic Therapy of Insomnia

Sleep: A Comprehensive Handbook

Volumn , Issue , 2005, Pages 125-132

  Lee Chiong, Teofilo ^a   Sateia, Michael ^b  

^a NATIONAL JEWISH MEDICAL AND RESEARCH CENTER   (United States)

^b DARTMOUTH HITCHCOCK MEDICAL CENTER   (United States)

Author keywords

Hypnotic agents and chronic insomnia; Neurochemistry of sleep; Pharmacologic therapy of insomnia

Indexed keywords

EID: 40749156504     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/0471751723.ch17     Document Type: Chapter

References (29)

1. Qureshi A, Lee-Chiong T. Medications and their effects on sleep. Med Clin N Am 88:751-766(2004).
2. Terzano MG, Rossi M, Palomba V, Smerieri A, Parrino L. New drugs for insomnia: comparative tolerability of zopiclone, zolpidem and zaleplon. Drug Saf 26(4):261-282(2003).
3. Schweizer E, Rickels K. Benzodiazepine dependence and withdrawal: a review of the syndrome and its clinical management. Acta Psychiatr Scand Suppl 393:95-101(1998).
4. Bélanger L, Morin CM, Bastien CH, Guay B, Leblanc J, Vallières A, Radouco-Thomas M. Benzodiazepine discontinuation in chronic insomnia: a survival analysis over a 24-month follow-up [abstract]. Sleep 26(Suppl):A308-A309(2003).
5. Walsh JK, Vogel GW, Scharf M, Erman M, William Erwin C, Schweitzer PK, Mangano RM, Roth T. A five week, polysomnographic assessment of zaleplon 10 mg for the treatment of primary insomnia. Sleep Med 1(1):41-49(2000).
6. Noble S, Langtry HD, Lamb HM. Zopiclone. An update of its pharmacology, clinical efficacy and tolerability in the treatment of insomnia. Drugs 55(2):277-302(1998).
7. Krystal AD, Walsh JK, Laska E, Caron J, Amato DA, Wessel TC, Roth T. Sustained efficacy of eszopiclone over 6 months of nightly treatment: results of a randomized, double-blind, placebo-controlled study in adults with chronic insomnia. Sleep 26(7):793-799(2003).
8. Hajak G,Muller WE,Wittchen HU, Pittrow D, KirchW. Abuse and dependence potential for the non-benzodiazepine hypnotics zolpidem and zopiclone: a review of case reports and epidemiological data. Addiction 98(10):1371-1378(2003).
9. Saletu-Zyhlarz GM, Abu-Bakr MH, Anderer P, Gruber G, Mandl M, Strobl R, Gollner D, Prause W, Saletu B. Insomnia in depression: differences in objective and subjective sleep and awakening quality to normal controls and acute effects of trazodone. Prog Neuropsychopharmacol Biol Psychiatry 26(2):249-260(2002).
10. Winokur A, DeMartinis NA 3rd, McNally DP, Gary EM, Cormier JL, Gary KA. Comparative effects of mirtazapine and fluoxetine on sleep physiology measures in patients with major depression and insomnia. J Clin Psychiatry 64(10):1224-1229(2003).
11. Cohrs S, Rodenbeck A, Guan Z, Pohlmann K, JordanW, Meier A, Ruther E. Sleep-promoting properties of quetiapine in healthy subjects. Psychopharmacology (Berl) 174(3):421-429(2004).
12. Sproule BA, Busto UE, Buckle C, Herrmann N, Bowles S. The use of non-prescription sleep products in the elderly. Int J Geriatr Psychiatry 14(10):851-857(1999).
13. Rickels K, Morris RJ, Newman H, Rosenfeld H, Schiller H, Weinstock R. Diphenhydramine in insomniac family practice patients: a double-blind study. J Clin Pharmacol 23(5-6):234-242(1983).
14. Almeida Montes LG, Ontiveros Uribe MP, Cortes Sotres J, Heinze Martin G. Treatment of primary insomnia with melatonin: a double-blind, placebo-controlled, crossover study. J Psychiatry Neurosci 28(3):191-196(2003).
15. Zhdanova IV, Wurtman RJ, Regan MM, Taylor JA, Shi JP, Leclair OU. Melatonin treatment for age-related insomnia. J Clin Endocrinol Metab 86(10):4727-4730(2001).
16. Lehrl S. Clinical efficacy of kava extract WS 1490 in sleep disturbances associated with anxiety disorders. Results of a multicenter, randomized, placebo-controlled, double-blind clinical trial. J Affect Disord 78(2):101-110(2004).
17. Fugh-Berman A, Jerry M, Cott J. Dietary supplements and natural products as psychotherapeutic agents. Psychosom Med 61:712-728(1999).
18. Donath F, Quispe S, Diefenbach K, Maurer A, Fietze I, Roots I. Critical evaluation of the effect of valerian extract on sleep structure and sleep quality. Pharmacopsychiatry 33(2):47-53(2000).
19. Stevinson C, Ernst E. Valerian for insomnia: a systematic review of randomized clinical trials. Sleep Med 1(2):91-99(2000).
20. Walsh JK, Lankford DD, Krystal A, Roth T, Jochelson P, Garber M, Alexander T, Burke J. Efficacy and tolerability of four doses of indiplon (NBI-34060) modified-release in elderly patients with sleep maintenance insomnia [abstract]. Sleep 26(Suppl):A78(2003).
21. Roth T, Walsh J. Phase II study of the selective ML-1 receptor agonist TAK-375 in a first night effect model of transient insomnia [abstract]. Sleep 26(Suppl):A294(2003).
22. Erman M, Seiden D, Zammit G. Phase II study of the selective ML-1 receptor agonist TAK-375 in subjects with primary chronic insomnia [abstract]. Sleep 26(Suppl):A298(2003).
23. Curran HV, Collins R, Fletcher S, Kee SC, Woods B, Iliffe S. Older adults and withdrawal from benzodiazepine hypnotics in general practice: effects on cognitive function, sleep, mood and quality of life. Psychol Med 33(7):1223-1237(2003).
24. Baillargeon L, Landreville P, Verreault R, Beauchemin JP, Gregoire JP, Morin CM. Discontinuation of benzodiazepines among older insomniac adults treated with cognitive-behavioural therapy combined with gradual tapering: a randomized trial. CMAJ 169(10):1015-1020(2003).
25. Jindal RD, Buysse DJ, Thase ME. Maintenance treatment of insomnia: What can we learn from the depression literature? Am J Psychiatry 161:19-24(2004).
26. Mendelson WB, Roth T, Cassella J, Roehrs T, Walsh JK, Woods JH, Buysse DJ, Meyer RE. The treatment of chronic insomnia: drug indications, chronic use and abuse liability. Summary of a 2001 New Clinical Drug Evaluation Unit Meeting Symposium. Sleep Med Rev 8(1):7-17(2004).
27. Montplaisir J, Hawa R, Moller H, Morin C, Fortin M, Matte J, Reinish L, Shapiro CM. Zopiclone and zaleplon vs benzodiazepines in the treatment of insomnia: Canadian consensus statement. Hum Psychopharmacol 18(1):29-38(2003).
28. Neubauer DN. Pharmacologic approaches for the treatment of chronic insomnia. Clin Cornerstone 5(3):16-27(2003).
29. Roehrs T, Roth T. Hypnotics: an update. Curr Neurol Neurosci Rep 3(2):181-184(2003).